Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Aprea Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 34 | 27 | −7 |
| Shares | 2.03M | 1.71M | −327.2K (−16.1%) |
| Value | $1.52M | $1.11M | −$410.7K (−27.0%) |
New holders (1)
Institutions that held Aprea Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 61,847 | $40.2K | 0.00% |
Sold out (8)
Institutions that held Aprea Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Jane Street Group, LLC | 71,959 | $54.0K |
| D. E. Shaw & Co., Inc. | 49,750 | $37.0K |
| Crestline Management, LP | 48,819 | $36.0K |
| Virtu Financial LLC | 19,664 | $15.0K |
| Citadel Advisors LLC | 18,881 | $14.0K |
| Bank of New York Mellon Corp | 16,643 | $12.0K |
| Quantamental Technologies LLC | 11,352 | $9.00K |
| Bank of America Corp | 198 | $0 |